Please select the option that best describes you:

Topics: PsoriasisDermatology

Would you stop bimekizumab in a patient who has severe psoriasis and has responded well to this therapy but is found to have newly diagnosed cirrhosis?   

Assuming numerous prior treatment failures, and no LFT elevation on lab monitoring for medication. 



Answer from: at Academic Institution
Sign In or Register to read more